479
Views
20
CrossRef citations to date
0
Altmetric
Research Article

New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment

, , , , , , , & show all
Pages 728-736 | Received 16 Oct 2013, Accepted 24 Feb 2014, Published online: 21 Mar 2014

References

  • Novak E, Franz TJ, Headington JT, Wester RC. Topically applied minoxidil in baldness. Int J Dermatol 1985;24:82–7
  • Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150:186–94
  • Tata S, Weiner N, Flynn G. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin. J Pharm Sci 1994;83:1508–10
  • Tata S, Flynn GL, Weiner ND. Penetration of minoxidil from ethanol/propylene glycol solutions: effect of application volume and occlusion. J Pharm Sci 1995;84:688–91
  • Edward S, Friedman BS, Friedman PM, et al. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol 2002;46:309–12
  • Balakrishnan P, Shanmugam S, Lee WS, et al. Formulation and in vitro assessment of minoxidil for enhanced skin delivery. Int J Pharm 2009;377:1–8
  • Mura S, Manconi M, Sinico C, et al. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 2009;380:72–9
  • Mura S, Manconi M, Valenti D, et al. Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target 2011;19:189–96
  • Zhao Y, Brown MB, Jones SA. The effects of particle properties on nanoparticle drug retention and release in dynamic minoxidil foams. Int J Pharm 2010;383:277–84
  • Mura S, Pirot F, Manconi M, et al. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007;15:101–8
  • Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997;14:556–67
  • Trapani G, Latrofa A, Franco M, et al. Inclusion complexation of propofol with 2-hydroxypropyl-β-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. J Pharm Sci 1998;87:514–18
  • Trapani G, Latrofa A, Franco M, et al. Complexation of phenytoin with some hydrophilic ciclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice. Eur J Pharm Biopharm 2001;52:65–73
  • Trapani G, Cutrignelli A, Latrofa A, et al. Valproic acid hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use. Drug Dev Ind Pharm 2004;30:53–64
  • Franco M, Montenegro L, Lopedota A, et al. Effect of some hydrophilic cyclodextrins on the solubulity, dissolution rate and in vitro percutaneous penetration of oxazepam. J Drug Del Sci Tech 2004;14:63–8
  • Guo B, Zhong S, Li N, et al. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 2013;39:1638–43
  • Calderini A, Pessine FBT. Syntesis and characterization of inclusion complex of the vasodilatator drug minoxidil with β-cyclodextrin. J Incl Phenom Macrocycl Chem 2008;60:369–77
  • Kim J, Lee M, Rang MJ. Minoxidil-containing dosage forms: skin retention and after-rinsing hair-growth promotion. Drug Deliv 2003;10:119–23
  • Loftsson T, Masson M. Cyclodextrin in topical drug formulations: theory and practice. Int J Pharm 2001;225:15–30
  • Vitoria M, Bentley B, Renata F, et al. Characterization of influence of some cyclodextrin on the stratum corneum from the hairless mouse. J Pharm Pharmacol 1997;49:397–402
  • Chiva Carvalho F, Calixto G, Narita Hatakeyama I, et al. Rheological, mechanical, and bioadhesive behavior of hydrogels to optimize skin delivery systems. Drug Dev Ind Pharm 2013;39:1750–7
  • Gu JM, Robinson JR, Leung SHS. Hydrogels. In: Swarbric J, Boylan JC, eds. Encyclopedia of phamaceutical technology. Vol. 7. New York: Marcel Dekker, Inc; 1993:133–8
  • Lee WR, Park JH, Kim K-H, et al. The biological effect of topical alginate treatment in an animal model of skin wound healing. Wound Rep Reg 2009;17:505–10
  • FDA Guidance for Industry: SUPAC-SS CMC 7. Non sterile Semisolid Dosage Forms. Scale-up and post approval changes: chemistry, manufacturing and controls. In vitro release testing and in vivo bioequivalence. USA Department of Health and Human Services FDA, Center For Drug Evaluation and Research; May 1997
  • Herkenne C, Naik A, Kalia YN, et al. Pig ear skin ex vivo as a model for in vivo derma to pharmacokinetic studies. Man Pharm Res 2006;23:1850–6
  • Caona T, Oliveira Costab AC, Leal de Oliveirac MA, et al. Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model. Int J Pharm 2010;391:1–6
  • Higuchi T, Connors KA. Phase solubility technique. In: Reilly CN, ed. Advances in analytical chemistry and instrumentation. Vol. 4. New York: Wiley-Interscience; 1965:117–212
  • Mourtas S, Aggelopulos CA, Klepetsanis P, et al. Complex hydrogel systems composed of polymers, liposomes, and cyclodextrins: implications of composition on rheological properties and aging. Langmuir 2009;25:480–8
  • Boulmedarat L, Grossiord JL, Fattal E, Bochot A. Influence of methyl-beta-cyclodextrin and liposomes on rheological properties of Carbopol 974P NF gels. Int J Pharm 2003;254:59–64
  • Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35
  • Macheras P, Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharm Res 2000;17:108–12
  • Kaneko Y, Sakai K, Okano T. Temperature-responsive hydrogels as intelligent materials. In: Okano T, ed. Biorelated polymers and gels: controlled release and applications. San Diego (CA): Biomedical Engineering Academic Press; 1998:29–69
  • Zuleger S, Lippold BC. Polymer particle erosion controlling drug release. Factors influencing drug release and characterization of the release mechanism. Int J Pharm 2001;217:139–52
  • Szejtli J. Cyclodextrin technology. Dordrecht: Kluwer; 1988
  • Loftsson T, Brewster ME. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci 2012;101:3019–32
  • Francisco B, Pessine T, Calderini A, et al. Review: cyclodextrin inclusion complexes probed by NMR techniques. In: Kim DH, ed. Magnetic resonance spectroscopy. USA: In Tech; 2012:237–64
  • Patel J, Patel B, Banwait H, et al. Formulation and evaluation of topical aceclofenac gel using different gelling agent. Int J Drug Dev Res 2011;3:156–64
  • Trottet L, Merly C, Mirza M, et al. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int J Pharm 2004;274:213–19
  • Acarturk F, Celebi N. Cyclodextrins as bioavailability enhancers. In: Bilensoy E, ed. Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: current and future industrial applications. 1st ed. New York: John Wiley & Sons, Inc.; 2011:45–64
  • Dhamecha DL, Rathi AA, Saifee M, et al. Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharmaceut Sci 2009;1:24–46
  • Higuchi T. Physical chemical analysis of percutaneous absorption process from cream and ointments. J Soc Cos Chem 1960;11:85–97

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.